183 related articles for article (PubMed ID: 32070246)
1. Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial.
Ng SM; Turner MA; Weindling AM
Thyroid; 2020 Jul; 30(7):948-954. PubMed ID: 32070246
[No Abstract] [Full Text] [Related]
2. An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks' gestation: results of the TIPIT trial.
Ng SM; Turner MA; Gamble C; Didi M; Victor S; Manning D; Settle P; Gupta R; Newland P; Weindling AM
Trials; 2013 Jul; 14():211. PubMed ID: 23841945
[TBL] [Abstract][Full Text] [Related]
3. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
[TBL] [Abstract][Full Text] [Related]
4. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants.
van Wassenaer AG; Briët JM; van Baar A; Smit BJ; Tamminga P; de Vijlder JJ; Kok JH
Pediatrics; 2002 Sep; 110(3):534-9. PubMed ID: 12205256
[TBL] [Abstract][Full Text] [Related]
5. Effect of thyroxine on brain microstructure in extremely premature babies: magnetic resonance imaging findings in the TIPIT study.
Ng SM; Turner MA; Gamble C; Didi M; Victor S; Atkinson J; Sluming V; Parkes LM; Tietze A; Abernethy LJ; Weindling AM
Pediatr Radiol; 2014 Aug; 44(8):987-96. PubMed ID: 24671720
[TBL] [Abstract][Full Text] [Related]
6. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
van Wassenaer AG; Kok JH; de Vijlder JJ; Briët JM; Smit BJ; Tamminga P; van Baar A; Dekker FW; Vulsma T
N Engl J Med; 1997 Jan; 336(1):21-6. PubMed ID: 8970936
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone supplementation in preterm infants born before 28 weeks gestational age and neurodevelopmental outcome at age 36 months.
van Wassenaer-Leemhuis A; Ares S; Golombek S; Kok J; Paneth N; Kase J; LaGamma EF
Thyroid; 2014 Jul; 24(7):1162-9. PubMed ID: 24684245
[TBL] [Abstract][Full Text] [Related]
8. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial.
van Wassenaer AG; Westera J; Houtzager BA; Kok JH
Pediatrics; 2005 Nov; 116(5):e613-8. PubMed ID: 16234230
[TBL] [Abstract][Full Text] [Related]
9. Supplemental Iodide for Preterm Infants and Developmental Outcomes at 2 Years: An RCT.
Williams FLR; Ogston S; Hume R; Watson J; Stanbury K; Willatts P; Boelen A; Juszczak E; Brocklehurst P;
Pediatrics; 2017 May; 139(5):. PubMed ID: 28557747
[TBL] [Abstract][Full Text] [Related]
10. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age.
Briët JM; van Wassenaer AG; Dekker FW; de Vijlder JJ; van Baar A; Kok JH
Pediatrics; 2001 Apr; 107(4):712-8. PubMed ID: 11335749
[TBL] [Abstract][Full Text] [Related]
11. TIPIT: a randomised controlled trial of thyroxine in preterm infants under 28 weeks gestation: magnetic resonance imaging and magnetic resonance angiography protocol.
Ng SM; Turner MA; Gamble C; Didi M; Victor S; Malamateniou C; Parkes LM; Tietze A; Gregory L; Sluming V; Abernethy L; Weindling AM
BMC Pediatr; 2008 Jun; 8():26. PubMed ID: 18590560
[TBL] [Abstract][Full Text] [Related]
12. Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT.
Dorling J; Hewer O; Hurd M; Bari V; Bosiak B; Bowler U; King A; Linsell L; Murray D; Omar O; Partlett C; Rounding C; Townend J; Abbott J; Berrington J; Boyle E; Embleton N; Johnson S; Leaf A; McCormick K; McGuire W; Patel M; Roberts T; Stenson B; Tahir W; Monahan M; Richards J; Rankin J; Juszczak E
Health Technol Assess; 2020 Apr; 24(18):1-94. PubMed ID: 32342857
[TBL] [Abstract][Full Text] [Related]
13. Neurodevelopmental outcome of nutritional intervention in newborn infants at risk of neurodevelopmental impairment: the Dolphin neonatal double-blind randomized controlled trial.
Andrew MJ; Parr JR; Montague-Johnson C; Laler K; Holmes J; Baker B; Sullivan PB
Dev Med Child Neurol; 2018 Sep; 60(9):897-905. PubMed ID: 29806081
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Thyroid function in very preterm newborns: possible implications.
Van Wassenaer AG; Kok JH; Briët JM; Pijning AM; de Vijlder JJ
Thyroid; 1999 Jan; 9(1):85-91. PubMed ID: 10037082
[TBL] [Abstract][Full Text] [Related]
16. Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial.
Keim SA; Boone KM; Klebanoff MA; Turner AN; Rausch J; Nelin MA; Rogers LK; Yeates KO; Nelin L; Sheppard KW
JAMA Pediatr; 2018 Dec; 172(12):1126-1134. PubMed ID: 30357263
[TBL] [Abstract][Full Text] [Related]
17. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden.
Serenius F; Källén K; Blennow M; Ewald U; Fellman V; Holmström G; Lindberg E; Lundqvist P; Maršál K; Norman M; Olhager E; Stigson L; Stjernqvist K; Vollmer B; Strömberg B;
JAMA; 2013 May; 309(17):1810-20. PubMed ID: 23632725
[TBL] [Abstract][Full Text] [Related]
18. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation.
Carlo WA; McDonald SA; Fanaroff AA; Vohr BR; Stoll BJ; Ehrenkranz RA; Andrews WW; Wallace D; Das A; Bell EF; Walsh MC; Laptook AR; Shankaran S; Poindexter BB; Hale EC; Newman NS; Davis AS; Schibler K; Kennedy KA; Sánchez PJ; Van Meurs KP; Goldberg RN; Watterberg KL; Faix RG; Frantz ID; Higgins RD;
JAMA; 2011 Dec; 306(21):2348-58. PubMed ID: 22147379
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants.
Fewtrell MS; Morley R; Abbott RA; Singhal A; Isaacs EB; Stephenson T; MacFadyen U; Lucas A
Pediatrics; 2002 Jul; 110(1 Pt 1):73-82. PubMed ID: 12093949
[TBL] [Abstract][Full Text] [Related]
20. Maternal High-Dose DHA Supplementation and Neurodevelopment at 18-22 Months of Preterm Children.
Guillot M; Synnes A; Pronovost E; Qureshi M; Daboval T; Caouette G; Olivier F; Bartholomew J; Mohamed I; Massé E; Afifi J; Hendson L; Lemyre B; Luu TM; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Ducruet T; Ndiaye ABKT; Angoa G; Sériès T; Piedboeuf B; Nuyt AM; Fraser W; Mâsse B; Lacaze-Masmonteil T; Lavoie PM; Marc I
Pediatrics; 2022 Jul; 150(1):. PubMed ID: 35652296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
